Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR2 | O95665 | 4/20 | 0.45 |
| ▸ | NTSR1 | P30989 | 4/20 | 0.45 |
| ▸ | BACE1 | P56817 | 3/20 | 0.42 |
| ▸ | SORT1 | Q99523 | 3/20 | 0.41 |
| ▸ | MAGI3 | Q5TCQ9 | 1/20 | 0.40 |
| ▸ | MDM4 | O15151 | 1/20 | 0.39 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.39 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.39 |
| ▸ | CDK2 | P24941 | 2/20 | 0.39 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.39 |
| ▸ | F2 | P00734 | 2/20 | 0.39 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.39 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30338373 | 0.94 | BACE1 (0.46) | NTSR2NTSR1BACE1MAGI3 | |
| SCHEMBL31180771 | 0.92 | NTSR2 (0.46) | NTSR2NTSR1BACE1SORT1CCNA2 | |
| SCHEMBL30368368 | 0.89 | GLP1R (0.42) | BACE1MDM4MDM2C5AR1 | |
| SCHEMBL31256965 | 0.89 | BACE1 (0.48) | BACE1CCNA2CDK2CCNA1 | |
| SCHEMBL30433504 | 0.86 | NTSR2 (0.48) | NTSR2NTSR1BACE1SORT1MDM4 | |
| SCHEMBL31574018 | 0.86 | BACE1 (0.44) | BACE1 | |
| SCHEMBL10619527 | 0.86 | BACE1 (0.48) | BACE1CCNA2CDK2CCNA1 | |
| SCHEMBL10619539 | 0.86 | BACE1 (0.48) | BACE1CCNA2CDK2CCNA1 | |
| SCHEMBL29435292 | 0.85 | BACE1 (0.51) | BACE1F2 | |
| SCHEMBL29732685 | 0.85 | SLC15A2 (0.44) | NTSR2NTSR1SLC15A2C5AR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118159552-A | Novel peptides as potent and selective GIP receptor agonists | 赛诺菲 | 2024-06-07 | — | — | CN | disclosed |
| US-20230103631-A1 | PEPTIDES AS SELECTIVE GIP RECEPTOR AGONISTS | SANOFI (FR) | 2023-04-06 | — | — | US | disclosed |
| CN-115884982-A | Peptides as selective GIP receptor agonists | 赛诺菲 | 2023-03-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230103631-A1 | PEPTIDES AS SELECTIVE GIP RECEPTOR AGONISTS | GIPR, GLP1R, GPR119 | NTSR2 30/4885NTSR1 24/4885BACE1 3319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.